3,4-methylenedioxyamphetamine and 1-(3,4-methylenedioxyphenyl)-2-butanamine

3,4-methylenedioxyamphetamine has been researched along with 1-(3,4-methylenedioxyphenyl)-2-butanamine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's4 (57.14)18.2507
2000's2 (28.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoffman, AJ; Jacob, P; Nichols, DE; Oberlender, RA; Shulgin, AT1
Clare, BW1
Andurkar, S; Clark, CR; DeRuiter, J; Noggle, FT1
Bronson, ME; Clark, CR; DeRuiter, J; Jiang, W1
Bollani, T; Favretto, D; Garofano, L; Guidugli, F; Patri, P; Santoro, M; Traldi, P1
Kurosu, A; Kuroyanagi, K; Matsushima, K; Nagai, T; Nihei, H; Saotome, A; Suzuki, A; Tokudome, S1
Ishii, H; Nakagawa, Y; Ogata, A; Suzuki, T; Tayama, S1

Other Studies

7 other study(ies) available for 3,4-methylenedioxyamphetamine and 1-(3,4-methylenedioxyphenyl)-2-butanamine

ArticleYear
Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class.
    Journal of medicinal chemistry, 1986, Volume: 29, Issue:10

    Topics: Adult; Animals; Butylamines; Dioxoles; Discrimination Learning; Female; Generalization, Stimulus; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Psychotropic Drugs; Rats; Rats, Inbred Strains; Structure-Activity Relationship

1986
The frontier orbital phase angles: novel QSAR descriptors for benzene derivatives, applied to phenylalkylamine hallucinogens.
    Journal of medicinal chemistry, 1998, Sep-24, Volume: 41, Issue:20

    Topics: Hallucinogens; Humans; Models, Molecular; Molecular Conformation; Phenethylamines; Quantum Theory

1998
Methods for the analysis of 1-(3,4-methylenedioxyphenyl)-2-butanamine and N-methyl-1-(3,4-methylenedioxyphenyl)-2-propanamine (MDMA).
    Journal of chromatographic science, 1991, Volume: 29, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Chromatography, Liquid; Forensic Medicine; N-Methyl-3,4-methylenedioxyamphetamine

1991
Effects of designer drugs on the chicken embryo and 1-day-old chicken.
    Brain research bulletin, 1994, Volume: 34, Issue:2

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Animals, Newborn; Body Weight; Chick Embryo; Chickens; Designer Drugs; Dextroamphetamine; Embryonic and Fetal Development; Female; Models, Biological; N-Methyl-3,4-methylenedioxyamphetamine; Pregnancy; Prenatal Exposure Delayed Effects; Water

1994
Ion trap mass spectrometry for the characterization of N-methyl-1- (3,4-methylene-dioxyphenyl)-2-butanamine and N-ethyl-3,4- methylenedioxyamphetamine, two widely distributed street drugs.
    Rapid communications in mass spectrometry : RCM, 1998, Volume: 12, Issue:12

    Topics: 3,4-Methylenedioxyamphetamine; Designer Drugs; Gas Chromatography-Mass Spectrometry; Illicit Drugs

1998
Enantiomer analysis of a new street drug, 3,4-methylenedioxy-N-methyl-butanamine, in rat urine.
    Journal of analytical toxicology, 2002, Volume: 26, Issue:2

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Chromatography, High Pressure Liquid; Illicit Drugs; Male; Rats; Rats, Wistar; Stereoisomerism; Substance Abuse Detection

2002
Cytotoxic effects of 3,4-methylenedioxy-N-alkylamphetamines, MDMA and its analogues, on isolated rat hepatocytes.
    Archives of toxicology, 2009, Volume: 83, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Adenosine Triphosphate; Animals; Cell Death; DNA Damage; Hallucinogens; Hepatocytes; Male; Methamphetamine; Mitochondria, Liver; N-Methyl-3,4-methylenedioxyamphetamine; Oxidative Phosphorylation; Rats; Rats, Inbred F344; Time Factors

2009